MetLife Inc. (MET)
MetLife Broadens Settlement Solutions Portfolio With NQA-FA
MET is expanding its settlement portfolio with a new solution aimed at the growing market for non-physical injury claims.
MetLife, Inc. (MET) Presents at Morgan Stanley US Financials Conference 2026 Transcript
MetLife, Inc. (MET) Presents at Morgan Stanley US Financials Conference 2026 Transcript
MetLife: Not Exciting, But It Works
MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends.
Here's Why Investors Should Stay Neutral on MetLife Stock for Now
MET is backed by premium growth, AI-driven efficiency and strong liquidity, but volatile investment income and lower ROIC support a neutral view.
MetLife Q1 Earnings Call Highlights
MetLife NYSE: MET reported a strong start to 2026, with executives telling analysts that first-quarter results reflected broad-based growth across its operating businesses, favorable underwriting trends and disciplined capital management under its New Frontier strategy.
MET Tops Q1 EPS Estimates on Strong Investment Income and Volume Growth
MetLife posts a Q1 earnings beat as investment income, underwriting gains and strong segment growth lift profits and revenues.
MetLife, Inc. (MET) Q1 2026 Earnings Call Transcript
MetLife, Inc. (MET) Q1 2026 Earnings Call Transcript
MetLife (MET) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for MetLife (MET) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Exploring Analyst Estimates for MetLife (MET) Q1 Earnings, Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for MetLife (MET), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
Can Higher Investment Income Help MetLife Deliver a Q1 Earnings Beat?
MET heads into Q1 earnings with rising net investment income expectations, strong segment growth forecasts and a consensus EPS estimate up 13.3% year over year.
MetLife: A Great Time To Buy The Preferred Stock
MetLife preferred shares now yield over 6% as rising rates pressure prices, offering attractive risk/reward for long-term investors. MET's preferred dividends are well covered, with payout ratios under 4% of adjusted earnings and likely dropping to 3% as EPS grows. Series F preferred, MET.PR.F, trades at ~$19.25 for a 6.15% yield. Low payout ratio and strong balance sheet support continued payments.
The Case for Holding MetLife Stock: What Investors Need to Know
MetLife stock trades at a discounted 6.9X forward P/E, with global diversification and rising premiums supporting a potential rebound despite recent underperformance.
